Advanced Medical Solutions Group Regulatory News (AMS)

9 September 2025

Name of applicant:

Advanced Medical Solutions Group plc

Name of scheme:

Block Scheme for:

1. Deferred Share Bonus Scheme

2. Enterprise Management Incentive Scheme

3. Company Share Option Plan

4. Unapproved Executive Share Option Scheme

5. Long Term Incentive Plan

6. Deferred Annual Bonus Scheme

Period of return:

From:

6 March 2025

To:

5 September 2025

Balance of unallotted securities under scheme(s) from previous return:

1. 1,739

2. Nil

3. 129,543

4. 167,103

5. 13,886

6. 245,821

Plus:  The amount by which the block scheme(s) has been increased since the date of the last return (if any increase has been applied for):

1. Nil

2. Nil

3. Nil

4. Nil

5. Nil

6. Nil

Less:  Number of securities issued/allotted under scheme(s) during period:

1. 1,739

2. Nil

3. 41,970

4. 82,562

5. 13,886

6. 16,059

Equals:  Balance under scheme(s) not yet issued/allotted at end of period:

1. Nil

2. Nil

3. 87,573

4. 84,541

5. Nil

6. 229,762

Number and class of securities originally listed and the date of admission:

4,476,264 ordinary shares of 5p each on 6 September 2018.

Name of contact:

Owen Bromley

Telephone number of contact:

01606 545514

Advanced Medical Solutions Group plc

Tel: +44 (0) 1606 545508

Chris Meredith, Chief Executive Officer

Eddie Johnson, Chief Financial Officer

Michael King, Investor Relations

Optimum Strategic Communications

Tel: +44 (0) 20 4566 8543

Mary Clark / Nick Bastin / Isabelle Abdou

AMS@optimumcomms.com

Investec Bank PLC (NOMAD & Broker)

Tel: +44 (0) 20 7597 5970

Gary Clarence / David Anderson

Berenberg (Joint Broker)

Tel: +44 (0) 20 3207 7800

Toby Flaux / Detlir Elezi / Yasmina Benchekroun